AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2011
Jun 6, 2011
34117_dirs_2011-06-06_6206f5c9-cb1b-49b2-a76c-e98bffa4e0bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-06-02
Reporting Person: HERMS HENRY P (Director, VP - Finance & CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-02 | Employee Stock Option | $0.37 | A | 100000 | Acquired | 2021-06-01 | Common Stock (100000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the Copytele, Inc. 2010 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6